Semnur Pharmaceuticals, Inc. Proceeds from Issuance of Private Placement
Semnur Pharmaceuticals, Inc. (SMNR) reported Proceeds from Issuance of Private Placement of $5.10 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-04-01
- Semnur Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $0.00.
- Semnur Pharmaceuticals, Inc. proceeds from issuance of private placement for fiscal 2022 was $5.10M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $5.10M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.10M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $5.10M 10-Q · filed 2023-08-15 |